Linda Ji has extensive experience representing domestic and international clients in connection with a wide range of corporate and commercial transactions, with a specialty focus on cross-border deals between China and the US. Linda represents clients ranging from startups to Fortune 500 companies in various industries, including emerging and high technologies, life sciences, consumer products, manufacturing and health care real estate. Linda develops strategies and practical solutions tailored to each client, taking into consideration their unique needs, laws and regulations of China, US and other jurisdictions, as well as tax treaties.
Linda has represented multiple Chinese and US companies in a variety of transactions in the US, including corporate structuring, new company formation, equity investments, venture capital financing, debt financings, mergers and acquisitions, IPOs and post-IPO compliance, joint ventures, technology licensing, strategic collaborations, as well as corporate governance, equity compensation and equity incentive plan, and other operational matters. Linda counsels China-based clients in connection with transactions involving US national security analysis and filings with the Committee on Foreign Investment in the United States (CFIUS).
Linda also advises US and European companies on doing business in China, on matters such as formation of WFOEs and JVs, acquisitions, compliance, IP enforcement and profits repatriation.
Prior to coming to the US, Linda worked at the Ministry of Commerce of PR China (MOFCOM) in Beijing. At MOFCOM, she participated in negotiating bilateral treaties between China and other countries concerning reciprocal protection of private investments, reviewing foreign investment projects and drafting laws and regulations concerning foreign investments in China.
Representing a leading Chinese life science company in connection with its expansion in the United States, including setting up subsidiaries, collaboration and licensing arrangements, office building purchases, and proposed acquisitions
Represented prominent Chinese investors in the US$930 million purchase of a health care real estate portfolio consisting of 39 senior housing and assisted living facilities throughout 11 states in the United States from Welltower Inc., a health care real estate investment trust (REIT)*
New England Chinese Information and Network Association (NECINA)
St. Louis University School of Law, JD, magna cum laude, 2000
St. Louis University School of Law, LLM, magna cum laude, 1994
University of International Business and Economics School of Law, LLB, Outstanding Graduate Award, 1990
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.